Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY2216684 adjunctive flexible-dose study in major depressive disorder
2010-021216-41Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in major depressive disorder (MDD) comparing LY2216684 adjunctive arm with Placebo adjunctive arm (2 arms). Primary endpoint: Change from baseline in MADRS total score. Started Nov 2010; status: completed.
02
Drugs
edivoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2010-021216-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021216-41.